Inferra AI / Company / ATR
Aptargroup, Inc.
ATR · Materials
Last earnings Oct 29, 2026
Key results
Reported net incomequarter
28%
Reported net income increased 28% to $128 million and reported
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
EPSquarter
30%
earnings per share increased 30% to $1.92 Adjusted ea rnings per share, which also excludes non-ordinary-course litigation costs (see Non-GAAP section for full definition), increased 4% to $1.62 Adjusted EBITDA, which also excludes non-ordinary-course litigation costs
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Reported net income increased 16% to $318 million and reported
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
earnings per share increased 17% to $4.75
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Adjusted earnings per share increased 7% to $4.48 Adjusted EBITDA increased 8% to $624 million, and Adjusted EBITDA margin was 22.2% compared to 21.2% in the prior year Returned $279 million to shareholders through share repurchases and dividends Aptar delivered solid third quarter results with strong product volume gr
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Total AptarGroup Reported revenuequarter
6%
1 Third Quarter Segment Sales Analysis (Change Over Prior Year) Aptar Pharma Aptar Beauty Aptar Closures Total AptarGroup Reported Sales Growth 6% 8% 1% 6% Currency Effects (1) (4)% (4)% (2)% (4)% Acquisitions 0% (4)% 0% (1)% Core Sales Growth 2% 0% (1)% 1% (1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Core revenuequarter
2%
1 Third Quarter Segment Sales Analysis (Change Over Prior Year) Aptar Pharma Aptar Beauty Aptar Closures Total AptarGroup Reported Sales Growth 6% 8% 1% 6% Currency Effects (1) (4)% (4)% (2)% (4)% Acquisitions 0% (4)% 0% (1)% Core Sales Growth 2% 0% (1)% 1% (1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Aptar reported third quarter earnings per share of $1.92 compared to $1.48 reported a year ago.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Adjusted earnings per share were $1.62, compared to the prior year period s adjusted earnings per share of $1.56, including comparable exchange rates.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
AI analysis
Q3 2025 · reported Oct 30, 2025
Based on: Earnings release + parent 8-K — transcript not held
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Reported net income | 28% | 24% | — |
| EPS | 30% | 18% | — |
| Total AptarGroup Reported revenue | 6% | 7% | — |
| Core revenue | 2% | 3% | — |
Guidance · company-stated
“for the fourth quarter of 2025 to be in the range of $1.20 to $1.28”
“range of 19.5% to 21.5%”
Guidance stated in the release for the fourth quarter of 2025; figures as stated.
Capital allocation
In the first nine months of 2025, free cash flow was $206 million, with the year-over-year decline primarily driven by higher working capital and pension contributions, partially offset by lower capital expenditures.
Event summary
Aptar Reports Third Quarter 2025 Results Crystal Lake, Illinois
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
adjusted earnings per share: “adjusted earnings per share for the fourth quarter of 2025 to be in the range of $1.20 to $1.28”
effective tax rate: “effective tax rate range of 19.5% to 21.5%”
adjusted earnings per share (“the fourth quarter of 2025”)
“Aptar currently expects adjusted earnings per share for the fourth quarter of 2025 to be in the range of $1.20 to $1.28.”
effective tax rate (“the fourth quarter of 2025”)
“This guidance is based on an effective tax rate range of 19.5% to 21.5%.”
Guidance stated in the release for the fourth quarter of 2025; figures as stated.
Capital allocation
In the first nine months of 2025, free cash flow was $206 million, with the year-over-year decline primarily driven by higher working capital and pension contributions, partially offset by lower capital expenditures.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
The company ended September with $265 million in cash and short-term investments, $936 million in net debt, and a leverage ratio of 1.22.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Cash Dividends and Share Repurchases As previously announced, Aptar s Board of Directors approved a quarterly cash dividend of $0.48 per s hare.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
During the third quarter, Aptar repurchased 286,000 shares for $40 million.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Free cash flow is calculated as cash provided by operating activities less capital expenditures plus proceeds from government grants related to capital expenditures.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Strategy & priorities
Our continued focus on innovation, operational excellence and disciplined capital deployment, positions us well to deliver sustainable value for our customers and shareholders, while expanding our third quarter adjusted EBITDA margin, said Stephan B.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
3 Presentation of Non-GAAP Information This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of restructuring initiatives, acquisition-related costs, certain purchase accounting adjustments related to acquisitions and investments and net unrealized investment gains and losses related to observable market price changes on equity securities, and other special items.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, restructuring initiatives, acquisition-related costs, net unrealized investment gains and losses related to observable market price changes on equity securities and other special items.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
We believe that it is meaningful to investors in evaluating our financial performance and measuring our ability to generate cash internally to fund our initiatives.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
$ 127,927 $ 100,039 $ 318,445 $ 273,597 Adjustments Restructuring initiatives 1,607 2,851 4,301 7,188 Curtailment gain related to restructuring initiatives (1,373) (1,373) Net investment loss (gain) 122 (788) (638) (1,129) Gain from remeasurement of equity method investment (26,518) (26,518) Transaction costs related to acquisitions 566 824 105 Purchase accounting adjustments related to acquisitions and investments 976 976 Other special items 3,322 3,322 Foreign currency effects (1) 4,734 5,077 Adjusted Net Income Attributable to AptarGroup, Inc.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Risks & headwinds
Adjusted EBITDA margin was 37.2%, which also excludes non-ordinary-course litigation costs, an increase of 120 basis point s, reflecting strong sales performance of higher value proprietary drug delivery systems and higher royalties.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
For the three and nine months ended September 30, 2025, Other special items include costs incurred related to non-ordinary-course litigation, specifically lawsuits between Aptar and ARS Pharmaceuticals, Inc.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Please refer to Legal Proceedings within Note 12 - Commitments and Contingencies within Aptar s Form 10-Q for the quarterly period ended September 30, 2025 for more information.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K and Form 10-Qs.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
What changed vs prior quarter
Reported net income — prior quarter passage and this quarter's passage are both cited.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
EPS — prior quarter passage and this quarter's passage are both cited.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Total AptarGroup Reported revenue — prior quarter passage and this quarter's passage are both cited.
SEC original ↗Aptargroup, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
33 documents- Q3 2026
- 8-KATR
Oct 29, 2026
- Q2 2026
- 8-KATR
Sep 21, 2026
- 8-KATR
Sep 10, 2026
- 8-KATR
Sep 1, 2026
- 10-QATR
Jul 31, 2026
- 8-KATR
Jul 30, 2026
- Q1 2026
- 8-KATR
May 13, 2026
- 8-KATR
May 7, 2026
- 10-QATR
May 1, 2026
- 8-KATR
Apr 30, 2026
- Q4 2025
- 8-KATR
Mar 17, 2026
- 10-KATR
Feb 6, 2026
- 8-KATR
Feb 5, 2026
- Q3 2025
- 8-KATR
Nov 20, 2025
- 10-QATR
Oct 31, 2025
- 8-KATR
Oct 30, 2025
- Q2 2025
- 10-QATR
Aug 1, 2025
- 8-KATR
Jul 31, 2025
- Q1 2025
- 8-KATR
May 8, 2025
- 10-QATR
May 2, 2025
- 8-KATR
May 1, 2025
- Q4 2024
- 10-KATR
Feb 7, 2025
- 8-KATR
Feb 6, 2025
- Q3 2024
- 10-QATR
Oct 25, 2024
- 8-KATR
Oct 24, 2024
- Q2 2024
- 10-QATR
Jul 26, 2024
- 8-KATR
Jul 25, 2024
- 8-KATR
Jul 25, 2024
- EX-99ATR
Jul 25, 2024
- EX-99ATR
Jul 25, 2024
- 8-KATR
Jul 3, 2024
- Q1 2024
- 8-KATR
May 2, 2024
- 10-QATR
Apr 26, 2024
Earnings releases
10 documentsPresentations
0 documentsNo presentations for Aptargroup, Inc. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Aptargroup, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.